Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

INTEL CORP Prospectus 2006

Jul 18, 2006

29808_prs_2006-07-18_8f08f878-8742-441f-ba9f-d128390adf4e.zip

Prospectus

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

424B3 1 f21310p6e424b3.htm 424B3 e424b3 PAGEBREAK

Filed under Rule 424(b)(3) and (7) of the Securities Act of 1933, relating to Registration No. 333-132865

Supplement No. 6 to Prospectus Supplement Dated March 31, 2006 and Prospectus Dated March 30, 2006

Intel Corporation

$1,600,000,000 2.95% Junior Subordinated Convertible Debentures due 2035

And

Shares of Common Stock Issuable Upon Conversion of the Debentures

This supplement no. 6 to the prospectus supplement dated March 31, 2006 and the prospectus dated March 30, 2006 relates to the resale by selling securityholders of Intel Corporation’s 2.95% Junior Subordinated Convertible Debentures Due 2035 and the shares of Intel common stock issuable upon conversion of the debentures.

You should read this supplement no. 6 in conjunction with the prospectus supplement dated March 31, 2006, the prospectus dated March 30, 2006, and all supplements to the prospectus supplement, which should be delivered in conjunction with this supplement no. 6. This supplement no. 6 is not complete without, and may not be delivered or used except in conjunction with, the prospectus and prospectus supplement, including supplement no. 1, supplement no. 2, supplement no. 3, supplement no. 4, supplement no. 5 and any other amendments or supplements to them. This supplement no. 6 is qualified by reference to the prospectus supplement and the prospectus, except to the extent that the information provided by this supplement no. 6 supersedes information contained in the prospectus supplement, supplement no. 1, supplement no. 2, supplement no. 3, supplement no. 4, and supplement no. 5.

Investing in the debentures and the common stock issuable upon conversion of the debentures involves risk. See the discussion entitled “Risk Factors” beginning on page S-5 of the prospectus supplement dated March 31, 2006.

PAGEBREAK

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this supplement no. 6, the prospectus supplement dated March 31, 2006 or the prospectus dated March 30, 2006. Any representation to the contrary is a criminal offense.

The table under the caption “Selling Securityholders” beginning on page S-54 of the prospectus supplement, as supplemented by supplement no. 1, supplement no. 2, supplement no. 3, supplement no. 4 and supplement no. 5, is hereby supplemented and amended by updating information as to certain selling securityholders identified in the table below and adding to it certain selling securityholders identified in the table below. We prepared this table based on information supplied to us by the selling securityholders named in the table below on or prior to July 17, 2006. Information about the selling securityholders may change over time. If required, any changed or new information given to us will be set forth in supplements to the prospectus supplement or amendments to the registration statement of which the prospectus, prospectus supplement and the supplements thereto, are a part, if and when necessary.

We have assumed for purposes of the table below that the selling securityholders will sell all of the debentures and all of the common stock issuable upon conversion of the debentures pursuant to this supplement no. 6, the prospectus supplement and the prospectus, and that any other shares of our common stock beneficially owned by the selling securityholders will continue to be beneficially owned.

Except as set forth below, none of the selling securityholders has, or within the past three years has had, any position, office or other material relationship with us or any of our predecessors or affiliates.

The selling securityholders identified below may have sold, transferred or otherwise disposed of, pursuant to transactions exempt from the registration requirements of the Securities Act of 1933, as amended, all or a portion of their debentures since the date on which they provided the information regarding their debentures.

PAGEBREAK

Principal Amount — of Debentures Number of Shares of Number of Shares of
Beneficially Percentage of Common Stock Common Stock Beneficially Natural Person(s) with
Owned and Debentures Issuable that May Be Owned after the Voting or Investment
Name of Selling Securityholder (1) Offered (USD) Outstanding (%) Sold(2)(3) Offering(4) Power
Ohio Insurance Co 275,000 * 8,722 0 Rob Young, Mike Witte
Medical Liability Mutual Ins Co 4,850,000 * 153,824 0 Rob Young, Mike Witte
S.A.C. Arbitrage Fund, LLC 15,000,000 * 475,743 106,500 Steven A. Cohen
Northern Income Equity Fund 8,000,000 * 253,730 0 (5)
JP Morgan Securities Inc. # 10,070,000 * 319,382 56,400 (6)
Independence Blue Cross 556,000 * 17,634 0 Tracy Maitland
The Police & Fire Retirement System of
the City of Detroit 437,000 * 13,860 0 Tracy Maitland
Georgia Municipal Employee Benefit System 1,105,000 * 35,046 0 Tracy Maitland
The Grable Foundation 69,000 * 2,188 0 Tracy Maitland
Trustmark Insurance Company 284,000 * 9,007 0 Tracy Maitland
FFV A Mutual Insurance Company 55,000 * 1,744 0 Tracy Maitland
ING Convertible Fund 950,000 * 30,130 0 Anuradha Sahai
American Express Funds — Convertible Bonds 60,000 * 1,903 0 (7)
Arctos Partners Inc. + 5,000,000 * 158,581 0 (8)
* Less than one percent (1%).
# The selling securityholder is a registered broker-dealer.
+ The selling securityholder is an affiliate of a registered broker-dealer.
(1) Information concerning other selling securityholders will be set forth in additional
supplements to the prospectus supplement from time to time, if required.
(2) Assumes conversion of all of the holder’s debentures at a conversion rate of 31.7162 shares of
common stock per $1,000 principal amount at maturity of the debentures. This conversion rate is
subject to adjustment as described under “Description of debentures—Conversion rights” in the
prospectus supplement. As a result, the number of shares of common stock issuable upon conversion
of the debentures may increase or decrease in the future. Excludes shares of common stock that may
be issued by us upon the repurchase of the debentures as described under “Description of
debentures—Fundamental change permits holders to require us to repurchase debentures” and
fractional shares. Holders will receive a cash adjustment for any fractional share amount resulting
from conversion of the debentures, as described under “Description of debentures—Conversion
rights.”

PAGEBREAK

| (3) | Calculated based on Rule 13d-3(d)(i) of the Exchange Act. The number of shares of common stock
beneficially owned by each holder named above is less than 1% of our outstanding common stock
calculated based on 5,883 million shares of common stock outstanding as of January 27, 2006. In
calculating this amount for each holder, we treated as outstanding the number of shares of common
stock issuable upon conversion of all of that holder’s debentures, but we did not assume conversion
of any other holder’s debentures. |
| --- | --- |
| (4) | For purposes of computing the number and percentage of debentures and shares of common stock to
be held by the selling securityholders after the conclusion of the offering, we have assumed for
purposes of the table above that the selling securityholders named above will sell all of the
debentures and all of the common stock issuable upon conversion of the debentures offered by this
prospectus, and that any other shares of our common stock beneficially owned by these selling
securityholders will continue to be beneficially owned. |
| (5) | The Northern Income Equity Fund (the “Fund”) is a registered investment company
advised by Northern Trust Investments (“NTI”), an investment adviser registered under the
Investment Advisers Act of 1940, as amended. NTI has sole voting and investment control with
respect to the securities owned by the Fund. Theodore T. Southworth is the portfolio manager of
the Fund. |
| (6) | JP Morgan Securities Inc. is a wholly-owned subsidiary of JP Morgan Chase & Co.,
which is a publicly traded company listed on the NYSE. |
| (7) | We have assumed based upon information available to us that American Express Funds -
Convertible Bonds is a subsidiary of a public company. |
| (8) | Arctos Partners Inc. is a wholly owned subsidiary of Bear Stearns Companies Inc., a publicly
traded company. |

The date of the supplement no. 6 is July 18, 2006